Zhu A - Search Results

1

Estimating causal log-odds ratio using the case-control sample and its application in the pharmaco-epidemiology study.

Zhu A, Zeng D, Zhang P, Li L. Zhu A, et al. Stat Methods Med Res. 2019 Jul;28(7):2165-2178. doi: 10.1177/0962280217750175. Epub 2018 Jan 22. Stat Methods Med Res. 2019. PMID: 29355073 Free PMC article.

2

A super-combo-drug test to detect adverse drug events and drug interactions from electronic health records in the era of polypharmacy.

Zhu A, Zeng D, Shen L, Ning X, Li L, Zhang P. Zhu A, et al. Stat Med. 2020 May 15;39(10):1458-1472. doi: 10.1002/sim.8490. Epub 2020 Feb 26. Stat Med. 2020. PMID: 32101641 Free PMC article.

3

MRLocus: Identifying causal genes mediating a trait through Bayesian estimation of allelic heterogeneity.

Zhu A, Matoba N, Wilson EP, Tapia AL, Li Y, Ibrahim JG, Stein JL, Love MI. Zhu A, et al. PLoS Genet. 2021 Apr 19;17(4):e1009455. doi: 10.1371/journal.pgen.1009455. eCollection 2021 Apr. PLoS Genet. 2021. PMID: 33872308 Free PMC article.

4

Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences.

Zhu A, Ibrahim JG, Love MI. Zhu A, et al. Bioinformatics. 2019 Jun 1;35(12):2084-2092. doi: 10.1093/bioinformatics/bty895. Bioinformatics. 2019. PMID: 30395178 Free PMC article.

5

Nonparametric expression analysis using inferential replicate counts.

Zhu A, Srivastava A, Ibrahim JG, Patro R, Love MI. Zhu A, et al. Nucleic Acids Res. 2019 Oct 10;47(18):e105. doi: 10.1093/nar/gkz622. Nucleic Acids Res. 2019. PMID: 31372651 Free PMC article.

6

Incidence and time course of neutropenia in patients treated with rituximab-based therapy for non-malignant immune-mediated hematologic diseases.

Malpica Castillo LE, Palmer S, Zhu A, Deal AM, Chen SL, Moll S. Malpica Castillo LE, et al. Among authors: zhu a. Am J Hematol. 2020 May;95(5):E117-E120. doi: 10.1002/ajh.25751. Epub 2020 Feb 17. Am J Hematol. 2020. PMID: 32017201 Free article. No abstract available.

7

Impact of Adherence to Ibrutinib on Clinical Outcomes in Real-World Patients With Chronic Lymphocytic Leukemia.

Garner LM, Kline T, Miller J, Deal A, Zhu A, Sketch MR, Coombs CC, Muluneh B. Garner LM, et al. Among authors: zhu a. J Adv Pract Oncol. 2021 Jan-Feb;12(1):20-28. doi: 10.6004/jadpro.2021.12.1.2. Epub 2021 Jan 1. J Adv Pract Oncol. 2021. PMID: 33552659 Free PMC article.

8

Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia.

Szeto AH, Bucci T, Deal A, Zhu A, Ahmad M, Cass AS, Sketch MR, Kemper R, Zeidner JF, Foster MC, Muluneh B, Crona DJ. Szeto AH, et al. Among authors: zhu a. Ann Pharmacother. 2022 Jul;56(7):753-763. doi: 10.1177/10600280211044160. Epub 2021 Sep 18. Ann Pharmacother. 2022. PMID: 34541881 Free article.

9

Adherence to infectious disease screening and immunization guidelines when treating non-malignant immune-mediated hematologic disorders.

Malpica-Castillo LE, Palmer S, Zhu A, Deal AM, Chen SL, Moll S. Malpica-Castillo LE, et al. Among authors: zhu a. Am J Hematol. 2020 Mar;95(3):E72-E75. doi: 10.1002/ajh.25710. Epub 2020 Jan 8. Am J Hematol. 2020. PMID: 31872481 Free article. No abstract available.

10

Acute Myeloid Leukemia with Co-mutated ASXL1 and SRSF2 Exhibits Monocytic Differentiation and has a Mutational Profile Overlapping with Chronic Myelomonocytic Leukemia.

Johnson SM, Richardson DR, Galeotti J, Esparza S, Zhu A, Fedoriw Y, Weck KE, Foster MC, Coombs CC, Zeidner JF, Montgomery ND. Johnson SM, et al. Among authors: zhu a. Hemasphere. 2019 Sep 11;3(4):e292. doi: 10.1097/HS9.0000000000000292. eCollection 2019 Oct. Hemasphere. 2019. PMID: 31942545 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,745 results

Search Page

Filters